

1,402,507 filings since 2004 · latest accepted Nov 4, 2026, 5:30 PM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Aug 8, 2024 accepted 7:29 AM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement3.03Holder rights modified | DocumentSEC ↗ |
May 3, 2024 accepted 4:02 PM ET | VNDAVanda Pharmaceuticals Inc. | Material agreement |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Apr 17, 2024 accepted 5:19 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement3.03Holder rights modified5.03Bylaws / fiscal year8.01Other events | DocumentSEC ↗ |
Dec 7, 2023 accepted 5:19 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement2.01Acquisition / disposition8.01Other events | DocumentSEC ↗ |
Jan 14, 2022 accepted 4:05 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
Jun 1, 2018 accepted 4:28 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement1.02Agreement terminated3.03Holder rights modified | DocumentSEC ↗ |
Mar 16, 2018 accepted 6:06 AM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Dec 8, 2016 accepted 7:01 AM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
Oct 24, 2016 accepted 4:33 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
Jun 24, 2016 accepted 4:59 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
May 12, 2016 accepted 4:31 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
Feb 4, 2016 accepted 9:02 AM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
Dec 22, 2014 accepted 4:06 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement1.02Agreement terminated | DocumentSEC ↗ |
Oct 29, 2014 accepted 9:59 AM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement5.03Bylaws / fiscal year8.01Other events | DocumentSEC ↗ |
Mar 21, 2014 accepted 7:01 AM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
Jan 28, 2014 accepted 7:00 AM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
Aug 7, 2013 accepted 4:08 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Apr 29, 2013 accepted 6:46 AM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
May 30, 2012 accepted 5:01 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
Apr 16, 2012 accepted 7:29 AM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Jul 27, 2011 accepted 8:33 AM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
Apr 19, 2010 accepted 4:34 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
Dec 22, 2009 accepted 5:07 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement3.03Holder rights modified5.02Officer / director change | DocumentSEC ↗ |
Oct 14, 2009 accepted 5:27 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement | DocumentSEC ↗ |
Sep 25, 2008 accepted 5:23 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement3.03Holder rights modified5.03Bylaws / fiscal year8.01Other events | DocumentSEC ↗ |
Jul 7, 2006 accepted 6:50 PM ET | VNDAVanda Pharmaceuticals Inc. | 1.01Material agreement5.02Officer / director change | DocumentSEC ↗ |